Clinical analysis of 114 cases of bronchiolitis in infants

Table 1 Basic information of children with bronchiolitis

Basic information
Gender, n (%)
Male	74 (64.9)
Female	40 (35.1)
Onset age, n (%)
1-6 mo	107 (93.9)
6-12 mo	7 (6.1)
Delivery, n (%)
Natural labour	71 (62.3)
Cesarean section	43 (37.7)
Time to hospital visit (d), n (%)
2-4	91 (79.8)
5-10	23 (20.2)
Length of stay (d)	7.1 ± 2.4
Co-infection with bacteria, n (%)	23 (20.2)
Cure rate, n (%)	108 (94.7)

Table 2 Clinical symptoms and imaging characteristics of children with bronchiolitis, n (%)

Bronchiolitis
Wheezing	47 (41.2)
Fever	12 (10.5)
Rhonchi	40 (35.1)
Crackles	22 (19.3)
Cyanosis	3 (2.6)
Increased lung texture	107 (93.8)
Patchy shadow	7 (6.1)

Table 3 Treatments for children with bronchiolitis, n (%)

Treatment
Antibiotic treatment	81 (71.1)
Hormone treatment	47 (41.2)
Antiviral treatment	81 (71.1)
Atomized medication
Budesonide + terbutaline	52 (45.6)
Budesonide + salbutamol	44 (38.5)

Table 4 Comparison of bronchiolitis children with bacterial infection and those with unknown bacterial infection

	Bacterial infection (n = 23)	Unknown bacterial infection (n = 91)	t/χ2	P value
Antibiotic treatment, n (%)	23 (100)	58 (63.7)	11.636	0.0001
Hormone treatment, n (%)	10 (43.5)	35 (38.5)	0.193	0.660
Antiviral treatment, n (%)	17 (73.9)	64 (70.3)	0.115	0.735
Atomized medication, n (%)			1.424	0.491
Budesonide + terbutaline	8 (34.8)	44 (48.4)
Budesonide + salbutamol	11 (47.8)	33 (36.3)
Length of stay (d)	7.3 ± 2.9	6.8 ± 2.3	0.959	0.735
Increased lung texture, n (%)	21 (91.3)	86 (94.5)	0.326	0.568
Wheezing, n (%)	11 (47.8)	36 (39.6)	0.518	0.472

¹Significant difference (chi-square test).

Table 5 Effect of antibiotics in children with bronchiolitis without bacterial infection

	Antibiotic treatment (n = 58)	No antibiotic treatment (n = 33)	t /χ2	P value
Length of stay (d)	7.8 ± 2.5	5.7 ± 1.8	4.291	0.0011
Cure rate, n (%)	57 (98.3)	29 (87.9)	4.331	0.0372

¹Significant difference (t-test).

²Significant difference (chi-square test).